WEBSITECHANGES

Website Changes

---

04/01/2024

Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma

---

03/30/2024

Low-Grade Glioma Webinar TOMORROW

---

03/29/2024

Prolonged use of certain hormone drugs linked to increased brain tumor risk

---

03/29/2024

Advocacy Alert for Washington Residents! Comment publicly to support Washington State HCA coverage of Tumor Treating Fields

---

03/28/2024

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

---

03/28/2024

First Participant Receives Sonodynamic Therapy for Glioblastoma in New Clinical Trial

---

03/25/2024

Oncovir Inc. is Pushing the Boundaries of Medical Innovation with Hiltonol

---

03/25/2024

Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta

---

03/25/2024

Bill would allow treatment for terminally ill before FDA approval

---

03/18/2024

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

---

03/18/2024

The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database

---

03/18/2024

Hoops For Hannah: , a March Madness bracket contest!

---

03/17/2024

Musella Foundation Copay Program now closed to new and renewal patients

---

03/14/2024

Early clinical trial results show `dramatic and rapid` regression of glioblastoma after next generation CAR-T therapy

---

03/14/2024

Gallium maltolate webinar added to website!

---

03/12/2024

Rod Norland`s book receives praise from brain tumor community

---

03/12/2024

Musella Foundation Copay Program Almost Closed!

---

03/10/2024

We’re having a webinar this Wednesday, March 13 at 7pm EST (6pm CST) on Gallium Maltolate!

---

03/10/2024

International war correspondent reflects on glioblastoma diagnosis in his memoir

---

03/10/2024

Tumor-Treating Fields Dosimetry in Glioblastoma: Insights into Treatment Planning, Optimization, and Dose-Response Relationships

---

03/10/2024

Phase 1 Car T cell trial shows promising results in high grade glioma

---

03/10/2024

New NIH Phase 1/2 clinical trial on Zotiraciclib for recurrent IDH-mutant gliomas

---

03/09/2024

Berberine as a potential enhancer for 5-ALA-mediated fluorescence in glioblastoma: increasing detectability of infiltrating glioma stem cells to optimize 5-ALA-guided surgery

---

02/29/2024

ADVANCED MRI BIOMARKERS PREDICT EARLY RESPONSE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA

---

02/29/2024

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

---